| Bioactivity | 8-Br-cGMP-AM is a derivative of 8-Br-cGMP. As an activator of PKG (cGMP-dependent protein kinase), it can lead to a variety of biological effects such as vasodilation and platelet inhibition. 8-Br-cGMP-AM can be used in the study of cardiovascular diseases[1]. |
| CAS | 272445-71-3 |
| Formula | C13H15BrN5O9P |
| Molar Mass | 496.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Butt E. cGMP-dependent protein kinase modulators[J]. cGMP: Generators, Effectors and Therapeutic Implications, 2009: 409-421. |
8-Br-cGMP-AM
CAS: 272445-71-3 F: C13H15BrN5O9P W: 496.16
8-Br-cGMP-AM is a derivative of 8-Br-cGMP. As an activator of PKG (cGMP-dependent protein kinase), it can lead to a vari
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.